Incidence and risk factors of venous Thromboembolic events in lymphoma

American Journal of Medicine

Volumn 123, Issue 10, 2010, Pages 935-941

  Zhou, Xiao ^a   Teegala, Shyam ^a   Huen, Auris ^a   Ji, Yuan ^a   Fayad, Luis ^a   Hagemeister, Fredrick B ^a   Gladish, Gregory ^a   Vadhan Raj, Saroj ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Lymphoma; Risk factor; Thrombosis

Indexed keywords

BLEOMYCIN; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ENOXAPARIN; HEMOGLOBIN; METHOTREXATE; METHYLPREDNISOLONE; VINBLASTINE; VINCRISTINE; WARFARIN; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LUNG EMBOLISM; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; VENOUS THROMBOEMBOLISM; BLOOD; COMPLICATION; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL MODEL; VENOUS THROMBOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CREATININE; DOXORUBICIN; FEMALE; HEMOGLOBINS; HUMANS; INCIDENCE; LOGISTIC MODELS; LYMPHOMA; MALE; METHOTREXATE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 77957793359     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.05.021     Document Type: Article

References (32)

1. P.D. Stein, A. Beemath, and F.A. Meyers Incidence of venous thromboembolism in patients hospitalized with cancer Am J Med 119 2006 60 68 (Pubitemid 43117468)
2. A.K. Kakkar, M.N. Levine, H.M. Pinedo, R. Wolff, and J. Wong Venous thrombosis in cancer patients: insights from the frontline survey Oncologist 8 2003 381 388
3. P. Prandoni, A. Falanga, and A. Picoli Cancer and venous thromboembolism Lancet Oncol 6 2005 401 410
4. P. Prandoni, A.W. Lensing, and A. Cogo The long-term clinical course of acute deep venous thrombosis Ann Intern Med 125 1996 1 7
5. H.K. Chew, T. Wun, and D. Harvey Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
6. A.A. Khorana, C.W. Francis, and E. Culakova Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 2007 632 634
7. S. Sallah, J.Y. Wan, and N.P. Nguyen Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thromb Haemost 87 2002 575 579
8. N. Goldschmidt, E. Linetsky, and E. Shalom High incidence of thromboembolism in patients with central nervous system lymphoma Cancer 98 2003 1239 1242
9. W.H. Geerts, G.F. Pineo, and J.A. Heit Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 338S 400S
10. J.W. Blom, C.J. Doggen, and S. Osanto Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 2005 715 722 (Pubitemid 40216041)
11. National Comprehensive Cancer Network Venous Thromboembolic Disease Clinical Practice Guidelines in Oncology (V.1.2007) http://www.nccn.org Accessed July 30, 2007
12. C.L. Bennett, S.M. Silver, and B. Djulbegovic Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia JAMA 299 2008 914 924
13. R.S. Komrokji, N.P. Uppal, and A.A. Khorana Venous thromboembolism in patients with diffuse large B-cell lymphoma Leuk Lymphoma 47 2006 1029 1033
14. M. Mohren, I. Markmann, and K. Jentsch-Ullrich Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis Br J Cancer 92 2005 1349 1351
15. H. Ottinger, C. Belka, and G. Kozole Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance Eur J Haematol 54 1995 186 194
16. A. Falanga, and F.R. Rickles Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies Hematology Am Soc Hematol Educ Program 2007 165 171
17. D.A. Hoppensteadt, and J.M. Walenga The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopenia Hematol Oncol Clin North Am 22 2008 1 18
18. M.G. Sarkiss, S.W. Yusuf, and C.L. Warneke Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes Cancer 109 2007 621 627
19. T. Simon, M. Beau Yon de Jonage-Canonico, and E. Oger Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism J Thromb Haemost 4 2006 71 76
20. J.W. Blom, J.P. Vanderschoot, and M.J. Oostindier Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: RESULTS: of a record linkage study J Thromb Haemost 4 2006 529 535
21. D. Molino, D. De Lucia, and R. Marotta In uremia, plasma levels of anti-protein C and anti-protein S antibodies are associated with thrombosis Kidney Int 68 2005 1223 1229
22. A. Segarra, P. Chacon, and C. Martinez-Eyarre Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis J Am Soc Nephrol 12 2001 1255 1263
23. E. Baskin, O. Duman, and N. Besbas Hypercoagulopathy in a hemodialysis patient: are elevations in factors VII and VIII effective? Nephron 83 1999 180
24. M.J. Johnson, M.W. Sproule, and J. Paul The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer Clin Oncol (R Coll Radiol) 11 1999 105 110
25. J. Miyagi, N. Funabashi, and M. Suzuki Predictive indicators of deep venous thrombosis and pulmonary arterial thromboembolism in 54 subjects after total knee arthroplasty using multislice computed tomography in logistic regression models Int J Cardiol 119 2007 90 94
26. A.A. Khorana, N.M. Kuderer, E. Culakova, G.H. Lyman, and C.W. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 2008 4902 4907
27. M. Henke, R. Laszig, and C. Rube Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial Lancet 362 2003 1255 1260
28. B. Leyland-Jones, V. Semiglazov, and M. Pawlicki Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study J Clin Oncol 23 2005 5960 5972
29. S. Vadhan-Raj, J.M. Skibber, and C. Crane Randomized, double-blind, placebo-controlled trial of epoetin alfa (Procrit) in patients with rectal and gastric cancer undergoing chemo-radiotherapy (CT/RT) followed by surgery: early termination of the trial due to increased incidence of thrombo-embolic events (TEE) 2004 ASH Annual Meeting Abstracts [Abstract 2915] Blood 104 2004 797a
30. C. Rella, M. Coviello, and F. Giotta A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy Breast Cancer Res Treat 40 1996 151 159
31. G.L. Nicolson, and S.E. Custead Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity Cancer Res 45 1985 331 336
32. M. Zangari, E. Siegel, and B. Barlogie Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy Blood 100 2002 1168 1171